Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

NCT02048371 is registered in ClinicalTrials.gov with Sarcoma Alliance for Research through Collaboration as lead sponsor.

NCT NCT02048371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02048371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Lead sponsor
Sarcoma Alliance for Research through Collaboration
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2014
Completion date
May 31, 2022
Enrollment
131 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

ewing/ewing-like sarcoma, liposarcoma, mesenchymal chondrosarcoma, osteogenic sarcoma, rhabdomyosarcoma